|
ARL6IP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.187090E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.785700E-04 |
| Normal-vs-Stage2 |
1.095590E-02 |
| Normal-vs-Stage3 |
5.582700E-03 |
| Normal-vs-Stage4 |
1.587770E-02 |
| Stage1-vs-Stage2 |
3.100400E-01 |
| Stage1-vs-Stage3 |
8.706000E-01 |
| Stage1-vs-Stage4 |
8.700600E-01 |
| Stage2-vs-Stage3 |
3.902200E-01 |
| Stage2-vs-Stage4 |
3.051200E-01 |
| Stage3-vs-Stage4 |
7.923200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.414700E-04 |
| Normal-vs-AfricanAmerican |
2.692200E-01 |
| Normal-vs-Asian |
5.341300E-03 |
| Caucasian-vs-AfricanAmerican |
5.063000E-01 |
| Caucasian-vs-Asian |
3.929000E-01 |
| AfricanAmerican-vs-Asian |
2.415000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.433800E-04 |
| Normal-vs-Female |
6.187500E-04 |
| Male-vs-Female |
3.361000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.724140E-03 |
| Normal-vs-Age(41-60Yrs) |
3.160000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.759660E-02 |
| Normal-vs-Age(81-100Yrs) |
2.392400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.570200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.811600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.388000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.821400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.531000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.510200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.177380E-01 |
| Classical-VS-Follicular |
2.367800E-02 |
| Classical-VS-Other |
8.460000E-01 |
| Classical-VS-Normal |
1.419160E-03 |
| Tall-VS-Follicular |
3.483800E-03 |
| Tall-VS-Other |
5.257000E-01 |
| Tall-VS-Normal |
8.126200E-01 |
| Follicular-VS-Other |
3.925000E-01 |
| Follicular-VS-Normal |
6.40659999999738E-05 |
| Other-VS-Normal |
2.729800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.30370000004121E-06 |
| Normal-vs-N1 |
2.989700E-02 |
| N0-vs-N1 |
4.913800E-01 |
|
|
